The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model

Abstract The pituitary gland plays an important endocrinal role, however its damage after cardiac arrest (CA) has not been well elucidated. The aim of this study was to determine a pituitary gland damage induced by CA. Rats were subjected to 10-min asphyxia and cardiopulmonary resuscitation (CPR). I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu Okuma, Tomoaki Aoki, Santiago J. Miyara, Kei Hayashida, Mitsuaki Nishikimi, Ryosuke Takegawa, Tai Yin, Junhwan Kim, Lance B. Becker, Koichiro Shinozaki
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7fc1625c4de34b6c93af84813e35c18c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7fc1625c4de34b6c93af84813e35c18c
record_format dspace
spelling oai:doaj.org-article:7fc1625c4de34b6c93af84813e35c18c2021-12-02T15:23:00ZThe evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model10.1038/s41598-020-79780-32045-2322https://doaj.org/article/7fc1625c4de34b6c93af84813e35c18c2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79780-3https://doaj.org/toc/2045-2322Abstract The pituitary gland plays an important endocrinal role, however its damage after cardiac arrest (CA) has not been well elucidated. The aim of this study was to determine a pituitary gland damage induced by CA. Rats were subjected to 10-min asphyxia and cardiopulmonary resuscitation (CPR). Immunohistochemistry and ELISA assays were used to evaluate the pituitary damage and endocrine function. Samples were collected at pre-CA, and 30 and 120 min after cardio pulmonary resuscitation. Triphenyltetrazolium chloride (TTC) staining demonstrated the expansion of the pituitary damage over time. There was phenotypic validity between the pars distalis and nervosa. Both CT-proAVP (pars nervosa hormone) and GH/IGF-1 (pars distalis hormone) decreased over time, and a different expression pattern corresponding to the damaged areas was noted (CT-proAVP, 30.2 ± 6.2, 31.5 ± 5.9, and 16.3 ± 7.6 pg/mg protein, p < 0.01; GH/IGF-1, 2.63 ± 0.61, 0.62 ± 0.36, and 2.01 ± 0.41 ng/mg protein, p < 0.01 respectively). Similarly, the expression pattern between these hormones in the end-organ systems showed phenotypic validity. Plasma CT-proAVP (r = 0.771, p = 0.025) and IGF-1 (r = −0.775, p = 0.024) demonstrated a strong correlation with TTC staining area. Our data suggested that CA induces pathological and functional damage to the pituitary gland.Yu OkumaTomoaki AokiSantiago J. MiyaraKei HayashidaMitsuaki NishikimiRyosuke TakegawaTai YinJunhwan KimLance B. BeckerKoichiro ShinozakiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yu Okuma
Tomoaki Aoki
Santiago J. Miyara
Kei Hayashida
Mitsuaki Nishikimi
Ryosuke Takegawa
Tai Yin
Junhwan Kim
Lance B. Becker
Koichiro Shinozaki
The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
description Abstract The pituitary gland plays an important endocrinal role, however its damage after cardiac arrest (CA) has not been well elucidated. The aim of this study was to determine a pituitary gland damage induced by CA. Rats were subjected to 10-min asphyxia and cardiopulmonary resuscitation (CPR). Immunohistochemistry and ELISA assays were used to evaluate the pituitary damage and endocrine function. Samples were collected at pre-CA, and 30 and 120 min after cardio pulmonary resuscitation. Triphenyltetrazolium chloride (TTC) staining demonstrated the expansion of the pituitary damage over time. There was phenotypic validity between the pars distalis and nervosa. Both CT-proAVP (pars nervosa hormone) and GH/IGF-1 (pars distalis hormone) decreased over time, and a different expression pattern corresponding to the damaged areas was noted (CT-proAVP, 30.2 ± 6.2, 31.5 ± 5.9, and 16.3 ± 7.6 pg/mg protein, p < 0.01; GH/IGF-1, 2.63 ± 0.61, 0.62 ± 0.36, and 2.01 ± 0.41 ng/mg protein, p < 0.01 respectively). Similarly, the expression pattern between these hormones in the end-organ systems showed phenotypic validity. Plasma CT-proAVP (r = 0.771, p = 0.025) and IGF-1 (r = −0.775, p = 0.024) demonstrated a strong correlation with TTC staining area. Our data suggested that CA induces pathological and functional damage to the pituitary gland.
format article
author Yu Okuma
Tomoaki Aoki
Santiago J. Miyara
Kei Hayashida
Mitsuaki Nishikimi
Ryosuke Takegawa
Tai Yin
Junhwan Kim
Lance B. Becker
Koichiro Shinozaki
author_facet Yu Okuma
Tomoaki Aoki
Santiago J. Miyara
Kei Hayashida
Mitsuaki Nishikimi
Ryosuke Takegawa
Tai Yin
Junhwan Kim
Lance B. Becker
Koichiro Shinozaki
author_sort Yu Okuma
title The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
title_short The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
title_full The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
title_fullStr The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
title_full_unstemmed The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
title_sort evaluation of pituitary damage associated with cardiac arrest: an experimental rodent model
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7fc1625c4de34b6c93af84813e35c18c
work_keys_str_mv AT yuokuma theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT tomoakiaoki theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT santiagojmiyara theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT keihayashida theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT mitsuakinishikimi theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT ryosuketakegawa theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT taiyin theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT junhwankim theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT lancebbecker theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT koichiroshinozaki theevaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT yuokuma evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT tomoakiaoki evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT santiagojmiyara evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT keihayashida evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT mitsuakinishikimi evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT ryosuketakegawa evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT taiyin evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT junhwankim evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT lancebbecker evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
AT koichiroshinozaki evaluationofpituitarydamageassociatedwithcardiacarrestanexperimentalrodentmodel
_version_ 1718387334983974912